175 related articles for article (PubMed ID: 25149293)
21. Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.
Xie YL; Rosen LB; Sereti I; Barber DL; Chen RY; Hsu DC; Qasba SS; Zerbe CS; Holland SM; Browne SK
Clin Infect Dis; 2016 Mar; 62(6):770-773. PubMed ID: 26646678
[TBL] [Abstract][Full Text] [Related]
22. IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.
Bai X; Ovrutsky AR; Kartalija M; Chmura K; Kamali A; Honda JR; Oberley-Deegan RE; Dinarello CA; Crapo JD; Chang LY; Chan ED
Int Immunol; 2011 Nov; 23(11):679-91. PubMed ID: 22033195
[TBL] [Abstract][Full Text] [Related]
23. Severe Disseminated Mycobacterium avium Infection in a Patient with a Positive Serum Autoantibody to Interferon-γ.
Ikeda H; Nakamura K; Ikenori M; Saito T; Nagamine K; Inoue M; Sakagami T; Suzuki H; Usui M; Kanemitsu K; Matsumoto A; Shinbo T
Intern Med; 2016; 55(20):3053-3058. PubMed ID: 27746449
[TBL] [Abstract][Full Text] [Related]
24. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
[TBL] [Abstract][Full Text] [Related]
25. Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency.
Horwitz ME; Uzel G; Linton GF; Miller JA; Brown MR; Malech HL; Holland SM
Blood; 2003 Oct; 102(7):2692-4. PubMed ID: 12805054
[TBL] [Abstract][Full Text] [Related]
26. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
27. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
Tomioka H; Maw WW; Sato K; Saito H
Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
[TBL] [Abstract][Full Text] [Related]
28. Adult-onset immunodeficiency in Thailand and Taiwan.
Browne SK; Burbelo PD; Chetchotisakd P; Suputtamongkol Y; Kiertiburanakul S; Shaw PA; Kirk JL; Jutivorakool K; Zaman R; Ding L; Hsu AP; Patel SY; Olivier KN; Lulitanond V; Mootsikapun P; Anunnatsiri S; Angkasekwinai N; Sathapatayavongs B; Hsueh PR; Shieh CC; Brown MR; Thongnoppakhun W; Claypool R; Sampaio EP; Thepthai C; Waywa D; Dacombe C; Reizes Y; Zelazny AM; Saleeb P; Rosen LB; Mo A; Iadarola M; Holland SM
N Engl J Med; 2012 Aug; 367(8):725-34. PubMed ID: 22913682
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 6 senses Mycobacterium avium and is required for efficient control of mycobacterial infection.
Marinho FA; de Paula RR; Mendes AC; de Almeida LA; Gomes MT; Carvalho NB; Oliveira FS; Caliari MV; Oliveira SC
Eur J Immunol; 2013 Sep; 43(9):2373-85. PubMed ID: 23716075
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency.
Ward CM; Jyonouchi H; Kotenko SV; Smirnov SV; Patel R; Aguila H; McSherry G; Dashefsky B; Holland SM
Eur J Pediatr; 2007 Sep; 166(9):981-5. PubMed ID: 17120031
[TBL] [Abstract][Full Text] [Related]
31. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
Tanimizu M; Mizuno K; Hashimoto M
Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
[TBL] [Abstract][Full Text] [Related]
32. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report.
Holland SM; Eisenstein EM; Kuhns DB; Turner ML; Fleisher TA; Strober W; Gallin JI
N Engl J Med; 1994 May; 330(19):1348-55. PubMed ID: 7908719
[TBL] [Abstract][Full Text] [Related]
33. Anti-interferon-gamma autoantibody related disseminated nontuberculous mycobacteriosis with pathological features of immunoglobulin G4-related disease.
Nagamura N; Imada T
Immunol Med; 2022 Mar; 45(1):48-53. PubMed ID: 34033731
[TBL] [Abstract][Full Text] [Related]
34. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
[TBL] [Abstract][Full Text] [Related]
35. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
[TBL] [Abstract][Full Text] [Related]
36. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
Kim SH; Cho D; Kim TS
Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
[TBL] [Abstract][Full Text] [Related]
37. Familial disseminated infection due to atypical mycobacteria with childhood onset.
Vesterhus P; Holland SM; Abrahamsen TG; Bjerknes R
Clin Infect Dis; 1998 Oct; 27(4):822-5. PubMed ID: 9798040
[TBL] [Abstract][Full Text] [Related]
38. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
[TBL] [Abstract][Full Text] [Related]
39. Disseminated
Chaononghin S; Visuttichaikit S; Apisarnthanarak A; Khawcharoenporn T
Int J Mycobacteriol; 2020; 9(1):91-94. PubMed ID: 32474495
[TBL] [Abstract][Full Text] [Related]
40. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
